Atenolol-induced lupus erythematosus - 11/09/11
Abstract |
Atenolol is a beta-blocker commonly used for treating hypertension. It can induce various kinds of adverse side effects, including psoriasiform skin eruptions, skin necrosis, vasculitis, and (rarely) drug-induced connective tissue disease. We encountered a patient receiving atenolol for his hypertension for 3 years who subsequently acquired connective tissue disease and antihistone antibodies. The initial serologic antinuclear antibody test was negative at a dilution of 1/20 but was postive after further serial dilutions, indicating the prozone phenomenon as the cause of the false-negative result. Six months after discontinuation of atenolol, the skin rash disappeared and antihistone antibody subsided. His skin rash reappeared on rechallenge with atenolol for 3 days, confirming that atenolol was responsible for his lupus erythematosus. (J Am Acad Dermatol 1997;37:298-9.)
Le texte complet de cet article est disponible en PDF.Plan
This article is made possible through an educational grant from the Dermatological Division, Ortho Pharmaceutical Corporation. |
|
Reprint requests: Jau-Shyong Deng, MD, Section of Dermatology, Medical Service, Department of Veterans Affairs Medical Center, University Drive C, Pittsburgh, PA 15240. |
|
16/4/79508 |
Vol 37 - N° 2P2
P. 298-299 - août 1997 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?